For research use only
| Cat No. | ABC-TC0189 |
| Product Type | Human Lung Cancer Cell Lines |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Lung Small Cell Cancer |
| Product Code | CORL95 |
COR-L95 Cell Line is a human small cell lung carcinoma model, widely used for oncology studies, drug response testing, and targeted therapy research.
COR-L95 is a human small cell lung carcinoma cell line derived from a bronchial biopsy of a 64-year-old male. This cell line grows in aggregated suspension, forming clusters in culture. In this cell line, copy number variation analysis revealed reduced copy numbers for several genes, including NMUR2 (neuromedin U receptor 2), LINC00607 (long intergenic non-protein coding RNA 607), and ACVR2A (activin A receptor, type IIA). These genomic alterations may influence receptor signaling, glycosylation pathways, and transcriptional regulation, potentially contributing to the molecular characteristics of this cancer model. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | CORL95 |
| Species | Human |
| Cat.No | ABC-TC0189 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Lung Small Cell Cancer |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Lung Cancer Cell Lines |
COR-L95 serves as a valuable in vitro model for studying small cell lung cancer (SCLC), a highly aggressive and metastatic malignancy. It is useful for investigating tumor proliferation, chemoresistance mechanisms, and metastatic behavior, which are key aspects of SCLC biology. Additionally, COR-L95 is utilized in genomic and proteomic studies to identify aberrant signaling pathways (e.g., MYC amplification, Notch signaling) and potential therapeutic targets.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
